Article
Mutant p27(Kip1) and its potential effect as hepatocellular gene therapy.
Archives of medical research - 1 Aug 2008
Lu Mudan, Fei Min, Cheng Chun, Wang You, He Song, Zhao Yueming, Gao Shangfeng, Ke Qing, Li Peng, Cui Xiaopeng, Shen Aiguo
Abstract excerpt
BACKGROUND: The cyclin-dependent kinase (cdk) inhibitor p27(Kip1) is an important regulator of cell cycle progression as it negatively regulates G(0/1) progression and plays a major role in controlling the cell cycle. The screening of the p27(Kip1) sequence identified many potential phosphorylation sites. To investigate the effects of the overexpression of exogenous p27(Kip1) protein lacking the Thr157 sites on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
